Back to search

National and Kapodistrian University of Athens

Μελέτη μοριακών μονοπατιών καρκινογένεσης σε καρκινώματα μαστού, με στόχο την ανάδειξη βιολογικών δεικτών για πρόγνωση και θεραπεία

Abstract

dc:description

Breast cancer is a a clinically and morphologically heterogeneous disease, the molecular basis of which has not been fully elucidated. Breast cancer research focuses on epigenetic modifications and signal transduction pathway molecules. In the present thesis, we studied DNA methylation of the promoters of selected genes and key-genesof PI3K/AKT pathway. We observed a berrant methylation of DCR1, DAPK1 and RASSF1A by MSP analysis and detected methylated loci in APC, MGMT, GSTP1 and PTEN promoters by MS-HRM in 49 breast cancer specimens. The results obtained by MS-HRMregarding the MGMT gene were validated by bisulfite pyrosequencing. An association of MGMT promoter methylation with age and tumour grade was recorded. Moreover, a correlation with advanced T-category was found for GSTP1, RASSF1 and DAPK1 promoter methylation. Finally, concurrent methylation of several genes showed a marginal statistical relationship with N-category reflecting the necessity for simultaneous detection of methylation in more than one gene in order to increase the clinical usefulness of methylation analyses for breast tumouri genesis. Further examination of genes displaying high methylation levels in larger cohorts could provide insight for new biomarkers for the early detection and/or disease monitoring, possibly influencing therapeutic decisions. Moreover, in the study of PI3K/AKT signaling pathway, we detected alterations at genetic level in 28% of breast carcinomas concerning PIK3CA(detection of a new mutation in breast cancer but also an extremely rare), in 4% ofAKT1 and 2.7% of PTEN, at epigenetic (methylation of PTEN) and transcriptional (statistically significantly increased expression of AKT2) level associated with clinicopathological features, revealing a very important role of this pathway in breast carcinogenesis. Our findings along with these of previous studies underlie the importance of PI3K/AKT pathway as a potential diagnostic marker of disease progression and as a potential therapeutic target. PI3K/AKT alterations in all aforementioned levels were detected mainly in breast carcinomas with positive expression of hormone receptors and HER2 contributing to elucidate the correlation of patient’s response to targeted therapies.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2012

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Tserga, Aggeliki
  • Τσέργα, Αγγελική

Subjects

dc:subject × 14

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/62589

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Tserga, Aggeliki; Τσέργα, Αγγελική. Μελέτη μοριακών μονοπατιών καρκινογένεσης σε καρκινώματα μαστού, με στόχο την ανάδειξη βιολογικών δεικτών για πρόγνωση και θεραπεία. National and Kapodistrian University of Athens, 2012. http://hdl.handle.net/10442/hedi/62589